Prosecution Insights
Last updated: July 17, 2026
Application No. 17/287,495

Current Source for Neurostimulation

Final Rejection §102
Filed
Apr 21, 2021
Priority
Oct 23, 2018 — AU 2018904014 +1 more
Examiner
FEDORKY, MEGAN TAYLOR
Art Unit
3796
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Saluda Medical Pty Ltd.
OA Round
4 (Final)
29%
Grant Probability
At Risk
5-6
OA Rounds
0m
Est. Remaining
76%
With Interview

Examiner Intelligence

Grants only 29% of cases
29%
Career Allowance Rate
10 granted / 34 resolved
-40.6% vs TC avg
Strong +47% interview lift
Without
With
+46.7%
Interview Lift
resolved cases with interview
Typical timeline
3y 11m
Avg Prosecution
29 currently pending
Career history
87
Total Applications
across all art units

Statute-Specific Performance

§101
2.7%
-37.3% vs TC avg
§103
78.8%
+38.8% vs TC avg
§102
14.2%
-25.8% vs TC avg
§112
4.0%
-36.0% vs TC avg
Black line = Tech Center average estimate • Based on career data from 34 resolved cases

Office Action

§102
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Status of Claims The amendments and remarks filed on 02MAR2026 have been entered and considered. Claims 1-8, 11-15, & 17-19 are currently pending. Claims 17 has been amended. claims 1-16 have been canceled. Claims 20-22 have been added. No new matter has been added. Claims 17-22 are under examination. Response to Arguments Applicant's arguments filed 02MAR2026 regarding the rejections under 35 USC 102(a)(1) have been fully considered and have been found to be not persuasive. Parts deemed not persuasive discussed below: Applicant states (see Page 6 of the Remarks): In other words, claim 17 expressly recites that in a first stimulus phase, the current injection current source is connected between the first supply rail and stimulus electrode such that it passes a first current from the first supply rail to the stimulus electrode, and that the at least one return electrode is connected to a second supply rail such that the first current flows from the return electrode to the second supply rail. Claim 17 further expressly recites that in a second stimulus phase, the current extraction current source is connected between the stimulus electrode and the second supply rail such that it passes a second current from the stimulus electrode to the second supply rail, and that the at least one return electrode is connected to the first supply rail such that the second current flows from the first supply rail to the return. Rather, Weiss appears to disclose connecting two active current sources to the electrodes during each of the stimulus phases. For example, Weiss at paragraph [0022] discloses, "During the stimulation phase, electrode El acts as the anode or source for the current pulse, while electrode E2 acts of the cathode or sink for the current pulse. Thus, sourced current of the desired amplitude is issued from the PDAC 72p to E1 while sunk current of that same amplitude is drawn into the NDAC 72n from E2.". Thus, during the stimulation phase in Weiss, two current sources are active, both electrodes are connected to a current source, and neither electrode is connected to a supply rail. The same is true in the active recovery phase: "The stimulation phase is eventually followed by the active recovery phase during which E1 acts as the cathode (sunk current is drawn into the NDAC 72n from E1) and E2 as the anode (source current is issued from PDAC 72p to E2), such that current flows through the tissue R in the opposite direction." Id. 1 [0022] (emphasis added). Thus, it is clear that in both the "stimulation phase" and the "active recovery phase," Weiss teaches that two current sources are active, both electrodes are connected to a current source, and neither electrode is connected to a supply rail. Accordingly, Weiss here fails to teach or suggest the features "the current injection current source is connected between a first supply rail and the stimulus electrode" and "the at least one return electrode is connected to a second supply rail" in the first stimulus phase; and "the current extraction current source is connected between the stimulus electrode and the second supply rail" and "the at least one return electrode is connected to the first supply rail" in the second stimulus phase as recited in amended claim 17. However, the Examiner disagrees because such as seen in Figure 3A the NDAC/PDAC units which are described in ¶022 are shown to have the supply rails (VH/GND) (i.e Compliance voltage to power the circuit and ground) which both need to be used for the operation of the circuitry. The examiner maintains that the reference teaches the claim limitations. Applicant states (see Pages 6-7 of the Remarks): In response to Applicant's previous arguments, the Office Action at page 5 asserted that Weiss teaches the connections recited in former claim 17, and asserted, "These parts as described are connected in a circuit to operate as a whole. The claim limitations do not provide further details on the configuration of the circuitry as argued, which states more than a circuit containing the relevant parts which are coupled together, since the amendments instead describe a general path of current as it flows through a circuit." However, Applicant submits that claim 17 as amended now recites more than "a general path of current as it flows through a circuit." Accordingly, Applicant submits that claim 17 as amended positively recites circuit configurations and operations that are not disclosed by Weiss. The Examiner notes the attempted amendment to disclose more than “a general path of current as it flows through a circuit”, but the amended language does not change either the scope or interpretation provided previously. Claim Rejections - 35 USC § 102 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. Claims 17-22 are rejected under pre-AIA 35 U.S.C. 102(a)(1) as being anticipated by Weiss et al. (US Publication Number 20180071513; Previously Cited). Regarding claim 17, Weiss discloses an implantable neurostimulator comprising (Weiss Abstract “Improved stimulation circuitry for controlling the stimulation delivered by an implantable stimulator is disclosed. The stimulation circuitry includes memory circuitry that stores pulse programs that define pulse shapes, steering programs that define electrode configurations, and aggregate programs that link a selected pulse program with a selected steering program.”; ¶0034):an implantable electrode array comprising at least one stimulus electrode and at least one return electrode, each electrode configured to deliver electrical stimuli to neural tissue (Weiss ¶0004 “The IPG 10 is coupled to electrodes 16 via one or more electrode leads 18, such that the electrodes 16 form an electrode array 20. The electrodes 16 are carried on a flexible body 22, which also houses the individual signal wires 24 coupled to each electrode. In the illustrated embodiment, there are eight electrodes (Ex) on two leads 18 for a total of sixteen electrodes 16, although the number of leads and electrodes is application specific and therefore can vary. The leads 18 couple to the IPG 10 using lead connectors 26,”; ¶0017; ); an implantable control module configured to produce the electrical stimuli delivered by the at least one stimulus electrode and at least one return electrode (Weiss ¶0025 “The microcontroller 50 in turn typically receives information about the structure of the pulses wirelessly from an external device, such as an external controller through which the patient or clinician could select the various pulse parameters (amplitude, pulse width, frequency), the electrodes, and whether they are to act as anodes or cathodes.”; ¶0063; ¶0069; ¶0121-¶0124), the control module comprising at least one current injection current source (Weiss ¶0018- ¶0022, Supply rails denoted as (VH, GND).) and at least one current extraction current source (Weiss ¶0018-¶0022 current extraction source denoted as NDAC 72n) wherein in a first stimulus phase the current injection current source is connected between a first supply rail and the stimulus electrode such that the current injection current source passes a first current from the first supply rail to the stimulus electrode (Weiss ¶0117 “Rows of the switches 178 in the switch matrix 190 are connected to nodes 191 in each of the electrodes' output paths. In the example shown, there are 25 branch transistors 184, and 33 electrode nodes (E1′ through E32′ and Ec′), and thus switch matrix 190 comprises 25 times 33 switches and control signals <Cn1> to control each. Of course, differing numbers of branch transistors and electrode nodes could also be used.”); the at least one return electrode is connected to a second supply rail such that the first current flows from the return electrode to the second supply rail (Weiss Figure 3A showing how the electrodes are in connected in the circuit to the supply rails and switching matrix. Further described in ¶0020 “one or more DACs (or one or more current sources within a DAC) may be distributed to a selected electrode by a switch matrix (not shown), in which case optional control signals <Psel> and <Nsel> would be used to control the switch matrix and establish the connection between the selected electrode and the PDAC 72p or NDAC 72n”) ; in a second stimulus phase, the current extraction current source is connected between the stimulus electrode and the second supply rail such that the current extraction current source pass a second current from the stimulus electrode to the second supply rail (Weiss Figure 5B showing the multiple components, extraction source NDAC, injection source PDAC, and switch matrix 190 which is not shown but described in ¶0117 “Rows of the switches 178 in the switch matrix 190 are connected to nodes 191 in each of the electrodes' output paths. In the example shown, there are 25 branch transistors 184, and 33 electrode nodes (E1′ through E32′ and Ec′), and thus switch matrix 190 comprises 25 times 33 switches and control signals <Cn1> to control each. Of course, differing numbers of branch transistors and electrode nodes could also be used.”;) the at least one return electrode is connected to the first supply rail such that the second current flows from the first supply rail to the return electrode. (Weiss Figures 3A & 3B; ¶0018- ¶0022, stimulus electrode (E1), return electrode (E2), first phase (stimulation phase), second phase (active recovery phase), current injection source (PDAC 72p), current extraction source (NDAC 72n), rails (VH, GND).). Regarding claim 18, Claim 17 is anticipated by Weiss. Weiss further discloses wherein the second supply rail is a ground rail (Weiss ¶0018- ¶0022, Supply rails denoted as (VH, GND).). Regarding claim 19, Claim 17 is anticipated by Weiss. Weiss further discloses wherein the first supply rail is a voltage supply rail (Weiss ¶0018- ¶0022, Supply rails denoted as (VH, GND).). Regarding claim 20, Weiss discloses a method of operating an implantable neurostimulator to deliver neural stimuli (Weiss Abstract “Improved stimulation circuitry for controlling the stimulation delivered by an implantable stimulator is disclosed. The stimulation circuitry includes memory circuitry that stores pulse programs that define pulse shapes, steering programs that define electrode configurations, and aggregate programs that link a selected pulse program with a selected steering program.”; ¶0034), the implantable neurostimulator comprising: an implantable electrode array comprising at least one stimulus electrode and at least one return electrode, each electrode configured to deliver electrical stimuli to neural tissue(Weiss ¶0004 “The IPG 10 is coupled to electrodes 16 via one or more electrode leads 18, such that the electrodes 16 form an electrode array 20. The electrodes 16 are carried on a flexible body 22, which also houses the individual signal wires 24 coupled to each electrode. In the illustrated embodiment, there are eight electrodes (Ex) on two leads 18 for a total of sixteen electrodes 16, although the number of leads and electrodes is application specific and therefore can vary. The leads 18 couple to the IPG 10 using lead connectors 26,”; ¶0017; ); a first supply rail and a second supply rail (Weiss ¶0018- ¶0022, Supply rails denoted as (VH, GND).); and a current injection current source and a current extraction current source (Weiss ¶0018-¶0022 current extraction source denoted as NDAC 72n) configured to produce the electrical stimuli delivered by the at least one stimulus electrode and at least one return electrode (Weiss ¶0025 “The microcontroller 50 in turn typically receives information about the structure of the pulses wirelessly from an external device, such as an external controller through which the patient or clinician could select the various pulse parameters (amplitude, pulse width, frequency), the electrodes, and whether they are to act as anodes or cathodes.”; ¶0063; ¶0069; ¶0121-¶0124), the method comprising: connecting, in a first stimulus phase, the current injection current source between the first supply rail and the stimulus electrode such that the current injection current source passes a first current from the first supply rail to the stimulus electrode (Weiss ¶0117 “Rows of the switches 178 in the switch matrix 190 are connected to nodes 191 in each of the electrodes' output paths. In the example shown, there are 25 branch transistors 184, and 33 electrode nodes (E1′ through E32′ and Ec′), and thus switch matrix 190 comprises 25 times 33 switches and control signals <Cn1> to control each. Of course, differing numbers of branch transistors and electrode nodes could also be used.”),connecting the at least one return electrode to the second supply rail during the first stimulus phase such that the first current flows from the return electrode to the second supply rail (Weiss Figure 3A showing how the electrodes are in connected in the circuit to the supply rails and switching matrix. Further described in ¶0020 “one or more DACs (or one or more current sources within a DAC) may be distributed to a selected electrode by a switch matrix (not shown), in which case optional control signals <Psel> and <Nsel> would be used to control the switch matrix and establish the connection between the selected electrode and the PDAC 72p or NDAC 72n”); connecting, in a second stimulus phase, the current extraction current source between the stimulus electrode and the second supply rail such that the current extraction current source passes a second current from the stimulus electrode to the second supply rail (Weiss Figure 5B showing the multiple components, extraction source NDAC, injection source PDAC, and switch matrix 190 which is not shown but described in ¶0117 “Rows of the switches 178 in the switch matrix 190 are connected to nodes 191 in each of the electrodes' output paths. In the example shown, there are 25 branch transistors 184, and 33 electrode nodes (E1′ through E32′ and Ec′), and thus switch matrix 190 comprises 25 times 33 switches and control signals <Cn1> to control each. Of course, differing numbers of branch transistors and electrode nodes could also be used.”;); and connecting the at least one return electrode to the first supply rail during the second stimulus phase such that the second current flows from the first supply rail to the return electrode. (Weiss Figures 3A & 3B; ¶0018- ¶0022, stimulus electrode (E1), return electrode (E2), first phase (stimulation phase), second phase (active recovery phase), current injection source (PDAC 72p), current extraction source (NDAC 72n), rails (VH, GND).). Regarding claim 21, Claim 20 is anticipated by Weiss. Weiss further discloses wherein the second supply rail is a ground rail. (Weiss ¶0018- ¶0022, Supply rails denoted as (VH, GND).). Regarding claim 22, Claim 20 is anticipated by Weiss. Weiss further discloses wherein the first supply rail is a voltage supply rail. (Weiss ¶0018- ¶0022, Supply rails denoted as (VH, GND).) Conclusion Applicant's amendment necessitated the new ground(s) of rejection presented in this Office action. Accordingly, THIS ACTION IS MADE FINAL. See MPEP § 706.07(a). Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a). A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any extension fee pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the date of this final action. Any inquiry concerning this communication or earlier communications from the examiner should be directed to MEGAN FEDORKY whose telephone number is (571)272-2117. The examiner can normally be reached M-F 9:30-4:30. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Jennifer McDonald can be reached on M-F 9:30-4:30. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /MEGAN T FEDORKY/ Examiner, Art Unit 3796 /UNSU JUNG/Supervisory Patent Examiner, Art Unit 3792
Read full office action

Prosecution Timeline

Show 4 earlier events
Mar 19, 2025
Interview Requested
Mar 25, 2025
Applicant Interview (Telephonic)
Mar 25, 2025
Examiner Interview Summary
Mar 31, 2025
Request for Continued Examination
Apr 01, 2025
Response after Non-Final Action
Nov 28, 2025
Non-Final Rejection mailed — §102
Mar 02, 2026
Response Filed
Jun 11, 2026
Final Rejection mailed — §102 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12527959
Compliance Voltage Monitoring and Adjustment in an Implantable Medical Device Using Low Side Sensing
4y 3m to grant Granted Jan 20, 2026
Patent 12396787
CATHETER WITH INTEGRATED THIN-FILM MICROSENSORS
4y 8m to grant Granted Aug 26, 2025
Patent 12376904
DYNAMIC LASER STABILIZATION AND CALIBRATION SYSTEM
3y 11m to grant Granted Aug 05, 2025
Patent 12350026
PHOTOPLETHYSMOGRAPHY SENSOR AND SEMICONDUCTOR DEVICE INCLUDING THE SAME
4y 4m to grant Granted Jul 08, 2025
Patent 12295647
HIGH DENSITY MAPPING CATHETER FOR CRYOBALOON ABLATION
4y 6m to grant Granted May 13, 2025
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

5-6
Expected OA Rounds
29%
Grant Probability
76%
With Interview (+46.7%)
3y 11m (~0m remaining)
Median Time to Grant
High
PTA Risk
Based on 34 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month